Pancreatic Cancer Research

ResearcherSecond Hospital of Shandong UniversityNo recent work listed

Shujun Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9103-7671; OpenAlex author ID A5100615534. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 2 papers

Papers 3

  1. DDX18 drives tumor immune escape through transcription-activated STAT1 expression in pancreatic cancer. Co-author DOI 10.1038/s41388-023-02817-0↗
  2. Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of CCL28. Co-author DOI 10.1038/s41416-023-02313-y↗
  3. The miR-141/neuropilin-1 axis is associated with the clinicopathology and contributes to the growth and metastasis of pancreatic cancer. Co-author DOI 10.1186/s12935-019-0963-2↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guoying Dong · 2 shared papers, 2023 · strength 0.35
  2. Chuanxin Wang · 2 shared papers, 2023 · strength 0.35
  3. Wei Gao · 1 shared paper, 2023 · strength 0.18
  4. Huaizhi Wang · 1 shared paper, 2023 · strength 0.18
  5. J J Li · 1 shared paper, 2023 · strength 0.16
  6. Jie Gao · 1 shared paper, 2023 · strength 0.16
  7. Xiaoyan Liu · 1 shared paper, 2023 · strength 0.16
  8. Hanxiang Zhan · 1 shared paper, 2023 · strength 0.16
  9. Lixin Ma · 1 shared paper, 2019 · strength 0.09
  10. Xueying Sun · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.